Literature DB >> 27816992

Impaired heart rate variability in cervical dystonia is associated to depression.

F Hentschel1, D Dressler2, M Abele3, S Paus4.   

Abstract

Causes of cardiovascular autonomic dysfunction in cervical dystonia (CD) are poorly understood. Studies examining effects of botulinum neurotoxin (BoNT) therapy on heart rate variability (HRV) yielded contradictory results. There is compelling evidence that depression shifts autonomic balance towards sympathetic predominance. As depression is the most frequent non-motor symptom in CD, we sought to determine if it is associated to dysfunction of cardiovascular autonomic regulation. Standardized interviews, clinical examinations, self-rating forms, autonomic symptom questionnaire, and automated autonomic testing in outpatients with idiopathic CD were used. Cardiovascular autonomic screening encompassed five different analyses of HRV, and testing of orthostasis. 85 CD patients participated in the study. 21% of them had HRV impairment, 14% orthostatic hypotension. 30% of CD patients had symptoms of depression. In those, decreased HRV was more frequent than in CD patients without mood disturbance (40 vs. 13%; p = 0.008). CD patients with and without depression had no other significant differences, including demographics, dystonia severity, comorbidity, medication, or BoNT therapy. Cardiovascular autonomic imbalance with sympathetic predominance is a non-motor manifestation of CD, associated to depression. Impaired HRV is a cardiovascular risk factor, moreover, emphasizing the need to identify and treat depression in dystonia.

Entities:  

Keywords:  Autonomic dysfunction; Cervical dystonia; Depression; Heart rate variability

Mesh:

Substances:

Year:  2016        PMID: 27816992     DOI: 10.1007/s00702-016-1639-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  43 in total

1.  Causal relationship between stressful life events and the onset of major depression.

Authors:  K S Kendler; L M Karkowski; C A Prescott
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

2.  Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial.

Authors:  R Tintner; R Gross; U F Winzer; K A Smalky; J Jankovic
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

3.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

4.  Effects of corticotropin-releasing factor on brain serotonergic activity.

Authors:  M L Price; A L Curtis; L G Kirby; R J Valentino; I Lucki
Journal:  Neuropsychopharmacology       Date:  1998-06       Impact factor: 7.853

5.  A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

Authors:  Mark S George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert Howland; Mitchel A Kling; Francisco Moreno; Barry Rittberg; David Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip Ninan; Paul Goodnick
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

Review 6.  Central control of autonomic function and involvement in neurodegenerative disorders.

Authors:  Maria G Cersosimo; Eduardo E Benarroch
Journal:  Handb Clin Neurol       Date:  2013

7.  Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.

Authors:  G A Heiman; R Ottman; R J Saunders-Pullman; L J Ozelius; N J Risch; S B Bressman
Journal:  Neurology       Date:  2004-08-24       Impact factor: 9.910

8.  Autonomic dysfunction: a link between depression and cardiovascular mortality? The FINE Study.

Authors:  Marjolein H Kamphuis; Mirjam I Geerlings; Jacqueline M Dekker; Simona Giampaoli; Aulikki Nissinen; Diederick E Grobbee; Daan Kromhout
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-12

Review 9.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.

Authors:  Guillaume Fond; Anderson Loundou; Nora Hamdani; Wahid Boukouaci; Aroldo Dargel; José Oliveira; Matthieu Roger; Ryad Tamouza; Marion Leboyer; Laurent Boyer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-06       Impact factor: 5.270

10.  Primary focal dystonia: evidence for distinct neuropsychiatric and personality profiles.

Authors:  R Lencer; S Steinlechner; J Stahlberg; H Rehling; M Orth; T Baeumer; H-J Rumpf; C Meyer; C Klein; A Muenchau; J Hagenah
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05-21       Impact factor: 10.154

View more
  2 in total

1.  Sexual dysfunction in cervical dystonia and blepharospasm.

Authors:  M Marek; M Grobe-Einsler; J R Bedarf; B Wabbels; S Paus
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-26       Impact factor: 2.570

2.  High prevalence of self-reported non-motor symptoms and lack of correlation with motor severity in adult patients with idiopathic isolated dystonia.

Authors:  Francisco Pereira da Silva-Júnior; Camila Oliveira Dos Santos Alves; Sônia Maria Cesar Azevedo Silva; Vanderci Borges; Henrique Ballalai Ferraz; Maria Sheila Guimarães Rocha; João Carlos Papaterra Limongi; Egberto Reis Barbosa; Patrícia de Carvalho Aguiar
Journal:  Neurol Sci       Date:  2021-07-23       Impact factor: 3.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.